AstraZeneca Agrees to Buy Alexion for $39 Billion
12 Dezember 2020 - 2:41PM
Dow Jones News
LONDON -- AstraZeneca PLC said it agreed to buy Boston-based
Alexion Pharmaceuticals Inc. for $39 billion in cash and stock, a
move that would bolster the British drug giant's footprint in
immunology and rare diseases.
(More to come)
(END) Dow Jones Newswires
December 12, 2020 08:26 ET (13:26 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
